D-0251-2026 Class II Ongoing
Recall Details
- Product Type
- Drugs
- Report Date
- January 14, 2026
- Initiation Date
- December 18, 2025
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 314 boxes of 6,280 pre-filled syringes
Product Description
Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852. NDC 71384-746-06.
Reason for Recall
Presence of particulate matter - Glass like particles.
Distribution Pattern
U.S Nationwide
Code Information
Lot: 25JAN033A, 25JAN033B, Expires: 02/12/2026.